The Joint That Runs the World's Surgical Robots

Part I

What a Harmonic Gear Reducer Actually Is, and Why It Matters

There is a component inside every joint of every da Vinci surgical robot, every collaborative robot arm on a car assembly line, every satellite antenna positioning system, and every wafer-handling mechanism in a semiconductor fabrication facility. Most people who work in these industries have never heard of it by name. It is called a harmonic gear reducer, or a strain wave gear. The precision it delivers in a small package has made it the default choice for robotic joints across industries where positioning accuracy cannot be compromised.

The physics behind it are worth understanding because they explain why the device is so hard to replicate. A conventional gear system, the kind you would find in a car gearbox, transmits torque through rigid teeth meshing against other rigid teeth. The gaps between those teeth create what engineers call backlash: a tiny amount of slop in the system that produces imprecision and wear. In most industrial applications, a small amount of backlash is tolerated and managed. Inside a robotic surgical arm operating within a human body, even a fraction of a degree of play translates into movement at the instrument tip that a surgeon cannot correct for.

A harmonic gear reducer solves this through elastic deformation rather than rigid meshing. It has three parts: a wave generator, which is an elliptical bearing assembly; a flexspline, a thin-walled cup of flexible steel with teeth on its outer rim; and a circular spline, a rigid outer ring with slightly more teeth than the flexspline. As the wave generator rotates, it deforms the flexspline into an elliptical shape, pressing its teeth against the circular spline at two contact points simultaneously. Because the tooth counts differ by two, each full rotation of the wave generator moves the flexspline backward by two teeth relative to the circular spline. The result is a gear reduction ratio that can reach 320:1 in a package small enough to fit inside a robotic wrist joint, with positional accuracy below one arc-minute and backlash measured in arc-seconds rather than degrees.

For a surgical robot, this translates directly into clinical performance. The surgeon's hand movements are scaled down and steadied, tremor is eliminated, and the instrument tip can be positioned with sub-millimetre repeatability, procedure after procedure, without cumulative drift. Medical-grade harmonic reducers must meet ISO 13485 quality management standards and sustain zero-backlash performance across a minimum of 10,000 surgical procedures, with consistent particulate control to prevent contamination of the surgical field.

Part II

The Competitive Structure, and Where the Cracks Are Forming

Harmonic Drive Systems Inc. of Japan holds 73 per cent of global market share in strain wave gears, a position it has held for decades on the back of an installed base exceeding 1.2 million units and a patent portfolio of more than 85 active filings. Nabtesco Corporation of Japan holds approximately 22 to 25 per cent of the broader harmonic reducer market, dominant in RV-type reducers used in heavy-payload industrial robots. Wittenstein SE of Germany and Schaeffler Technologies collectively account for an estimated 55 to 60 per cent of global market revenue alongside Harmonic Drive Systems, leaving a fragmented tail of regional and niche suppliers.

The market itself is growing at a pace that reflects the broader robotics expansion. The global harmonic drive system market was valued at $2.8 billion in 2025 and is projected to reach $6.1 billion by 2034, growing at a CAGR of 9.1 per cent. Within that total, medical devices represent approximately 15 to 18 per cent of application share and are the fastest-growing segment, driven by surgical robotics adoption across high-income markets and the early stages of adoption in emerging ones.

Medical-grade harmonic reducers command substantial pricing premiums over industrial-grade equivalents, and the barriers to entering this sub-market are materially higher. The barriers are not primarily technological. China's Leaderdrive, the most commercially advanced challenger to Japanese dominance, holds ISO 9001 quality management and ISO 14001 environmental certification, and is a main recipient of Chinese national certification for harmonic drive gear reducers for robots. What it does not hold is ISO 13485 medical device quality management certification. Medical-grade strain wave gear reducers must comply with ISO 13485, FDA 21 CFR Part 820, and sterilization compatibility requirements, and must deliver consistent zero-backlash performance over at least 10,000 surgical procedures. The qualification process for a new supplier in medical applications typically extends 12 to 24 months before a single unit ships to an OEM customer. Leaderdrive is not yet in that process for surgical applications.

Harmonic Drive Systems Inc. is actively scaling medical certifications including ISO 13485 and IEC 60601 alignment, targeting conversion of three OEM contracts into serial medical production within 12 to 18 months. The company that invented the technology is also the company most actively defending its medical-grade position against the Chinese challenger.

Part III

What the Dependency Means for Emerging Markets

Every emerging market manufacturer of surgical robots today is building systems around a component they cannot make themselves and cannot easily substitute. MicroPort in China and TINAVI in China have both brought surgical robotic systems to market. MicroPort's Toumai Tele-Robotic Surgical System received Chinese regulatory approval in May 2025. Both companies remain dependent on imported harmonic reducers for the precision joints in their systems, or on domestic alternatives that have not yet been qualified for the surgical-grade applications their products require.

India presents an even starker picture. The surgical robotics market in India is growing rapidly. Over 100 da Vinci systems are operational across major hospitals, with the market projected to expand at roughly 35 per cent annually through the remainder of the decade. India imports more than 70 per cent of its medical devices. There is no domestic harmonic reducer manufacturer operating at medical-grade qualification anywhere in India. Every surgical robot joint used in an Indian operating room was made in Japan, sourced through a supply chain with no local alternative.

The geopolitical dimension of this is becoming clearer to hospital procurement officers across emerging markets. The tariff environment since 2025 has drawn attention to single-country dependencies in high-technology components.

Three responses are underway. The first is localisation. China leads the most serious effort, with harmonic drive sales of 1,323,200 units in 2023, though the vast majority of Chinese domestic production remains in the industrial-grade segment. Leaderdrive has achieved scale, capturing approximately 15 per cent of global market share and 26 per cent of domestic Chinese market share by 2023, funded by institutional investors including SDIC Innovation Investment Management. The gap between industrial certification and medical certification remains the critical unresolved question.

The second response is design architecture. In June 2025, Wittenstein SE presented miniaturised Galaxie gearboxes and actuators with frameless motors and six-axis force sensors at automatica, targeting industrial and medical robots requiring low backlash within limited space. CMR Surgical's Versius system uses a modular arm design that reduces the number of precision reducers required per system, partially mitigating dependency per unit without eliminating it.

The third response is supply chain financing. Qualifying a new supplier for medical-grade harmonic reducers requires capital, for equipment, for the qualification process itself, and for the inventory buffer that OEM customers will require before committing to a new source. Most surgical robotics startups in emerging markets do not have access to it either.

Part IV

The Private Capital Opportunity

The harmonic gear reducer sits at an interesting intersection for private capital: it is a mechanical component, which tends to attract industrial investors, but its most consequential application is in medical devices, which attract healthcare investors. The two communities rarely look at the same deal flow, which means the intersection between them tends to be undercovered by both.

Three specific investment angles are worth examining in detail.

Supply chain financing for medical qualification. The most immediately actionable opportunity is providing structured credit or growth equity to companies actively pursuing ISO 13485 qualification for harmonic reducer production outside Japan. The pool of credible candidates is small. Leaderdrive is the most advanced, but its investor base is predominantly Chinese institutional capital, and the geopolitical risk associated with a Chinese-controlled supply alternative is itself a consideration for non-Chinese OEM customers. A South Korean, Taiwanese, or Southeast Asian alternative would be strategically more valuable to Western and GCC-aligned hospital systems. Spinea s.r.o. of Slovakia is worth noting here. It is cited alongside Harmonic Drive LLC as one of the suppliers of medical-grade harmonic reducers that meet ISO 13485 quality standards, serving a small but established position in medical robotics. European precision engineering companies at this scale, growing into medical-grade production, represent the kind of deal that a family office or a mid-market PE firm can access before the category attracts institutional healthcare fund attention.

GCC and South Asia market entry for existing precision gear suppliers. This angle suits Prakash Worldwide's operating geography directly. Distributors of precision gear components, whether Japanese, German, or European, face the same challenge in GCC and South Asian markets that surgical robotics manufacturers face: the local knowledge required to identify which hospital procurement cycles are active, which regulatory frameworks are moving toward recognising domestic surgical robotics, and which local partners can navigate the institutional relationships that determine whether a supply agreement converts into purchase orders. Saudi Vision 2030's hospital privatisation programme, which plans to transfer 295 hospitals to private operators, will create a wave of capital investment decisions in surgical technology over the next decade. Each of those procurement decisions will involve component supply choices. A precision gear supplier with established GCC distribution relationships is in a materially different competitive position than one approaching the market cold.

Private equity in the localisation play itself. The longer-horizon bet is direct equity in the company that qualifies the first credible ISO 13485-certified harmonic reducer alternative at scale outside Japan. It needs only to serve the portion of OEM demand that prefers supply chain diversification, which is growing with every geopolitical disruption to precision component availability. Qualifying a new supplier for medical-grade production takes years and demands capital that most precision engineering companies at this scale cannot self-fund. The market that waits at the other end is predictable, growing, and structurally protected by the same barriers that currently make entry difficult.

This note is produced for informational purposes only and does not constitute investment advice. Prakash Worldwide does not hold positions in any securities referenced herein. © 2026 Prakash Worldwide. All rights reserved.